In our study, both the TMB and MSI of COAD were positively correlated with the expression of MALT1, which supports our claim that MALT1 may be a good indicator of potential drug response (and MSI), as well as in COAD. This evidence concerns the gene MALT1 and colon adenocarcinoma.